On ECHEMI
Home > Drugs > Zhejiang Xianju Pharmaceutical Co., Ltd.
Zhejiang Xianju Pharmaceutical Co., Ltd.
  • Founded in:

    2000-06-26
  • Country:

    China China
  • Address:

    No. 1, Xianyao Road, Xianju County, Taizhou City, Zhejiang Province
  • Tax NO.:

    913300007047892221
  • Registered Funds:

    989.204866 million yuan
  • Website:

  • Email:

Related Drugs
Methylprednisolone
Sodium Succinate-6-Methylprednisolone
Name Description Content CAS NO. Registered Holders
Sodium Succinate-6-Methylprednisolone

Methylprednisolone is a synthetic glucocorticoid. It enters the cell nucleus and binds to DNA after penetrating the cell membrane and binding to specific receptors in the cytoplasm, initiating the transcription of mRNA and synthesizing various enzyme proteins. Its pharmacological effects include anti-inflammatory, immunosuppressive and anti-allergic properties, reducing immune active cells around inflammatory lesions, reducing vasodilation, stabilizing lysosomal membranes, inhibiting phagocytosis, reducing the production of prostaglandins and related substances; affecting carbohydrate, protein and fat metabolism, and also having effects on the cardiovascular system, skeletal and muscular system and central nervous system. The glucocorticoid-like effect of 4mg methylprednisolone is the same as that of 20mg hydrocortisone, and it has only a very low mineralocorticoid-like effect. In addition, it has the effect of decomposing proteins and fats and causes fat redistribution.

More

Methylprednisolone is a synthetic glucocorticoid. It enters the cell nucleus and binds to DNA after penetrating the cell membrane and binding to specific receptors in the cytoplasm, initiating the transcription of mRNA and synthesizing various enzyme proteins. Its pharmacological effects include anti-inflammatory, immunosuppressive and anti-allergic properties, reducing immune active cells around inflammatory lesions, reducing vasodilation, stabilizing lysosomal membranes, inhibiting phagocytosis, reducing the production of prostaglandins and related substances; affecting carbohydrate, protein and fat metabolism, and also having effects on the cardiovascular system, skeletal and muscular system and central nervous system. The glucocorticoid-like effect of 4mg methylprednisolone is the same as that of 20mg hydrocortisone, and it has only a very low mineralocorticoid-like effect. In addition, it has the effect of decomposing proteins and fats and causes fat redistribution.

0
Triamcinolone acetonide
Name Description Content CAS NO. Registered Holders
Triamcinolone acetonide

76-25-5 27
Cortisone acetate
Name Description Content CAS NO. Registered Holders
Cortisone acetate

Extract from the above information

More

Extract from the above information

50-04-4 11
Triamcinolone acetonide acetate
Name Description Content CAS NO. Registered Holders
Triamcinolone acetonide 21-acetate

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

3870-07-3 5
Hydrocortisone Butyrate
Name Description Content CAS NO. Registered Holders
Hydrocortisone-17-butyrate

Unspecified

More

Unspecified

13609-67-1 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.